It appears as though CRSP is forming a micro ascending triangle that is likely to result in bullish momentum.... The Williams Alligator is widening to the upside and there was recently a bullish cross. This is inherently bullish, but could always change in an instant....
Biotech in my opinion will be the biggest sector of growth in the 21st Century. Lot of value here in this ETF and it has the potential to explode in growth for a long time. Other good ETFs for this sector are ARKG IBB XBI. New highs in the next few years is my call on GNOM
CRISPR Therapeutics Short Term We look to Sell at 82.82 (stop at 88.85) Previous resistance located at 83.00. Short term oscillators have turned negative. Posted a Bearish Outside candle on the Daily chart. A lower correction is expected. Our profit targets will be 68.87 and 60.76 Resistance: 83.00 / 96.00 / 135.00 Support: 73.00 / 60.50 / 43.00 ...
CRISPR Therapeutics Short Term We look to Buy a break of 73.10 (stop at 68.66) Further upside is expected and we look to set longs in early trade. The trend of higher lows is located at 60.50. Previous resistance, now becomes support at 73.00. A higher correction is expected. Our profit targets will be 82.99 and 94.00 Resistance: 83.00 / 96.00 /...
CRISPR Therapeutics Short Term - We look to Buy a break of 59.19 (stop at 54.06) Further upside is expected and we look to set longs in early trade. A bullish reverse Head and Shoulders has formed. A break of yesterdays high would confirm bullish momentum. A higher correction is expected. Although the anticipated move higher is corrective, it does offer...
With more advances in gene-tech to come - This is my Bet.
I would buy 40% at this price then if the price drops to $30-40 I'd buy the rest of the 60%
CRSP CRISPR Therapeutics 52 Week Range 77.42 - 220.20 Now the price is 80.08usd. Bounced from its last support level. Barclays has a price target o 148usd for it. My price target by Q1 2022 is the 100usd resistance. Looking forward to read your opinion about it.
This is a daily chart of CRSP. As you can see, I marked the areas where high volume has occurred in the past. It's a little hard to see as I had to make the vertical lines almost transparent so you could see the candle and the volume I marked. In every recent case a high volume daily candle has marked a trend change. This may not be the case now, but from the...
Huge symmetrical triangle on the daily chart right at support. You might want to keep this on your watchlist for a possible break or reversal. - Factor Four
It appears as though CRSP is potentially bottoming out and forming an Ascending Triangle pattern. On the DMI there's been a bullish twist where I have placed the blue downward pointing finger. On the KST there's been a bullish cross where I have placed the blue check mark and upon back-testing the red line we've seen a bullish bounce where another check mark.
Currently, I'm holding $CRSP and have added more today on this 200 moving average support and wedge breakout.
Hello fellow traders. We are experiencing a respectable pullback on many names these past few days. CRISPR is one of them. This stock has actually been in correction for sometime now, which picked up pace after disappointing earnings last week. We may see more downside in the short term if the market continues the selloff but this company is definitely a buy in my...
CRISPR - Bullish - mid-term - Q1/Q2 possible route
EDIT had its little mini breakout and then fell down through support. Any chart I post please be sure to zoom out and do your own TA as well. I always stress risk manage and trade smart. Here we have EDIT bounce off 200MA with dragonfly doji, all happening at the bottom of a major trend line (4H chart). Nice risk/reward and solid upside potential here. Good luck!
Technical Analysis Since early December, we have had over a dozen tails on the purple up-trend arrow drawn in. The 50sma is now coming into play, as a break below that, could take us another 20% down to the 100sma. An appropriate level to exit the trade then, would be below the 50sma. There also horizontal support as we fill the gap. Important Note:...
Editas Medicine is a clinical stage genome editing company, With the help of CRISPR technology, it focuses on treating a range of serious diseases like: -Leber Congenital Amaurosis type 10 (Genetic form of vision loss that leads to blindness in childhood) - EDIT-101 has recently entered phase 1/2 trial for the treatment, the very first time an in vivo CRISPR...